Saroglitazar treatment prevents NASH, eliminates hepatocyte ballooning, and significantly improves serum LFTs, lipids and insulin resistance in DIAMOND(tm) mice compared to pioglitazone benchmark
| Autor: | Rebecca Caffrey, Jonathon Marioneaux, Prasanna K. Santhekadur, P. Bedossa, S. Giri, Archana Sanyal, M. Jain, B. Philip |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Hepatology Chemistry Saroglitazar Diamond engineering.material medicine.disease 030226 pharmacology & pharmacy 03 medical and health sciences Ballooning degeneration 0302 clinical medicine Insulin resistance Endocrinology Internal medicine engineering medicine 030211 gastroenterology & hepatology Pioglitazone medicine.drug |
| Zdroj: | Journal of Hepatology. 68:S578-S579 |
| ISSN: | 0168-8278 |
| DOI: | 10.1016/s0168-8278(18)31416-8 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect